Marilyn Kehry

Person

San Diego, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Antibodies directed against T cell immunoglobulin and mucin protein...
- Patent number 11,753,472
- Issue date Sep 12, 2023
- Tesaro, Inc.
- David J. King
- Y02 - TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMA...
Information Patent Grant
FcRn antibodies and methods of use thereof
- Patent number 11,732,047
- Issue date Aug 22, 2023
- Momenta Pharmaceuticals, Inc.
- Marilyn Kehry
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies directed against T Cell immunoglobulin and mucin protein...
- Patent number 11,352,427
- Issue date Jun 7, 2022
- AnaptysBio, Inc.
- Marilyn Kehry
- Y02 - TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMA...
Information Patent Grant
FcRn antibodies and methods of use thereof
- Patent number 11,345,751
- Issue date May 31, 2022
- Momenta Pharmaceuticals, Inc.
- Leona E. Ling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies directed against programmed death-1 (PD-1)
- Patent number 11,155,624
- Issue date Oct 26, 2021
- AnaptysBio, Inc.
- David J. King
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antibodies directed against lymphocyte activation gene 3 (LAG-3)
- Patent number 10,836,824
- Issue date Nov 17, 2020
- AnaptysBio, Inc.
- Helen Toni Jun
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies directed against programmed death-1 (PD-1)
- Patent number 10,738,117
- Issue date Aug 11, 2020
- AnaptysBio, Inc.
- David J. King
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
FcRn antibodies and methods of use thereof
- Patent number 10,676,526
- Issue date Jun 9, 2020
- Momenta Pharmaceuticals, Inc.
- Marilyn Kehry
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies directed against T cell immunoglobulin and mucin protein...
- Patent number 10,508,149
- Issue date Dec 17, 2019
- AnaptysBio, Inc.
- Marilyn Kehry
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
PD-1 binding proteins and methods of use thereof
- Patent number 10,428,145
- Issue date Oct 1, 2019
- Celgene Corporation
- Brydon Bennett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Rapid generation of anti-idiotypic antibodies
- Patent number 10,150,817
- Issue date Dec 11, 2018
- Biogen MA Inc.
- Robert J. Dunn
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies directed against programmed death-1 (PD-1)
- Patent number 9,815,897
- Issue date Nov 14, 2017
- AnaptysBio, Inc.
- David J. King
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
FcRn Antibodies and Methods of Use Thereof
- Publication number 20240158508
- Publication date May 16, 2024
- MOMENTA PHARMACEUTICALS, INC.
- Marilyn KEHRY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Antibody Agents Directed Against Lymphocyte Activation Gene-3 (LAG-...
- Publication number 20240158495
- Publication date May 16, 2024
- Tesaro, Inc.
- Helen Toni Jun
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Antibodies Directed Against T Cell Immunoglobulin and Mucin Protein...
- Publication number 20230416368
- Publication date Dec 28, 2023
- ANAPTYSBIO, INC.
- David J. King
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
B AND T LYMPHOCYTE ATTENUATOR (BTLA) MODULATORS AND METHOD OF USING...
- Publication number 20230391872
- Publication date Dec 7, 2023
- ANAPTYSBIO, INC.
- Martin Edward Dahl
- G01 - MEASURING TESTING
Information Patent Application
Antibodies Directed Against Programmed Death-1(PD-1)
- Publication number 20230331843
- Publication date Oct 19, 2023
- ANAPTYSBIO, INC.
- David J. King
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PD-1 Binding Proteins and Methods of Use Thereof
- Publication number 20230272076
- Publication date Aug 31, 2023
- Celgene Corporation
- Brydon Bennett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FcRn Antibodies and Methods of Use Thereof
- Publication number 20230049725
- Publication date Feb 16, 2023
- MOMENTA PHARMACEUTICALS, INC.
- Leona E. Ling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES DIRECTED AGAINST T CELL IMMUNOGLOBULIN AND MUCIN PROTEIN...
- Publication number 20220363759
- Publication date Nov 17, 2022
- AnaplysBio, Inc
- Marilyn KEHRY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PD-1 AGONIST AND METHOD OF USING SAME
- Publication number 20220235132
- Publication date Jul 28, 2022
- ANAPTYSBIO, INC.
- Marilyn KEHRY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES DIRECTED AGAINST T CELL IMMUNOGLOBULIN AND MUCIN PROTEIN...
- Publication number 20220169734
- Publication date Jun 2, 2022
- ANAPTYSBIO, INC.
- David J. King
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY AGENTS DIRECTED AGAINST LYMPHOCYTE ACTIVATION GENE-3 (LAG-...
- Publication number 20220135670
- Publication date May 5, 2022
- Tesaro, Inc.
- Helen Toni Jun
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibodies Directed Against Programmed Death-1 (PD-1)
- Publication number 20220089739
- Publication date Mar 24, 2022
- Tesaro, Inc.
- David J. King
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
FcRn Antibodies and Methods of Use Thereof
- Publication number 20210238275
- Publication date Aug 5, 2021
- Momenta Pharmaceuticals, Inc.
- Leona E. Ling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibodies Directed Against Programmed Death-1(PD-1)
- Publication number 20210163589
- Publication date Jun 3, 2021
- ANAPTYSBIO, INC.
- David J. King
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibodies Directed Against Lymphocyte Activation Gene 3 (LAG-3)
- Publication number 20210095026
- Publication date Apr 1, 2021
- ANAPTYSBIO, INC.
- Helen Toni JUN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FcRn Antibodies and Methods of Use Thereof
- Publication number 20200299382
- Publication date Sep 24, 2020
- Momenta Pharmaceuticals, Inc.
- Marilyn KEHRY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PD-1 BINDING PROTEINS AND METHODS OF USE THEREOF
- Publication number 20200255525
- Publication date Aug 13, 2020
- Celgene Corporation
- Brydon Bennett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES DIRECTED AGAINST T CELL IMMUNOGLOBULIN AND MUCIN PROTEIN...
- Publication number 20200148770
- Publication date May 14, 2020
- ANAPTYSBIO, INC.
- Marilyn KEHRY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES DIRECTED AGAINST T CELL IMMUNOGLOBULIN AND MUCIN PROTEIN...
- Publication number 20190284280
- Publication date Sep 19, 2019
- ANAPTYSBIO, INC.
- David J. King
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES DIRECTED AGAINST LYMPHOCYTE ACTIVATION GENE 3 (LAG-3)
- Publication number 20190256596
- Publication date Aug 22, 2019
- ANAPTYSBIO, INC.
- Helen Toni JUN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES DIRECTED AGAINST PROGRAMMED DEATH- 1 (PD-1)
- Publication number 20190256600
- Publication date Aug 22, 2019
- ANAPTYSBIO, INC.
- David J. King
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES DIRECTED AGAINST LYMPHOCYTE ACTIVATION GENE 3 (LAG-3)
- Publication number 20180127496
- Publication date May 10, 2018
- ANAPTYSBIO, INC.
- Helen Toni JUN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES DIRECTED AGAINST T CELL IMMUNOGLOBULIN AND MUCIN PROTEIN...
- Publication number 20180127500
- Publication date May 10, 2018
- ANAPTYSBIO, INC.
- Marilyn KEHRY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES DIRECTED AGAINST PROGRAMMED DEATH-1 (PD-1)
- Publication number 20180051082
- Publication date Feb 22, 2018
- ANAPTYSBIO, INC.
- David J. King
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FCRN ANTIBODIES AND METHODS OF USE THEREOF
- Publication number 20180016334
- Publication date Jan 18, 2018
- Momenta Pharmaceuticals, Inc.
- Marilyn KEHRY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PD-1 BINDING PROTEINS AND METHODS OF USE THEREOF
- Publication number 20170088618
- Publication date Mar 30, 2017
- Celgene Corporation
- Brydon Bennett
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES DIRECTED AGAINST PROGRAMMED DEATH-1 (PD-1)
- Publication number 20160075783
- Publication date Mar 17, 2016
- ANAPTYSBIO, INC.
- David J. King
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Rapid Generation of Anti-Idiotypic Antibodies
- Publication number 20130330323
- Publication date Dec 12, 2013
- Robert J. Dunn
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Anti-mouse CD20 antibodies and uses thereof
- Publication number 20070136826
- Publication date Jun 14, 2007
- Biogen Idec Inc.
- Robert Joseph Dunn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Marilyn Kehry

Person

Patents Grantslast 30 patents

Antibodies directed against T cell immunoglobulin and mucin protein...

FcRn antibodies and methods of use thereof

Antibodies directed against T Cell immunoglobulin and mucin protein...

FcRn antibodies and methods of use thereof

Antibodies directed against programmed death-1 (PD-1)

Antibodies directed against lymphocyte activation gene 3 (LAG-3)

Antibodies directed against programmed death-1 (PD-1)

FcRn antibodies and methods of use thereof

Antibodies directed against T cell immunoglobulin and mucin protein...

PD-1 binding proteins and methods of use thereof

Rapid generation of anti-idiotypic antibodies

Antibodies directed against programmed death-1 (PD-1)

Patents Applicationslast 30 patents

FcRn Antibodies and Methods of Use Thereof

Antibody Agents Directed Against Lymphocyte Activation Gene-3 (LAG-...

Antibodies Directed Against T Cell Immunoglobulin and Mucin Protein...

B AND T LYMPHOCYTE ATTENUATOR (BTLA) MODULATORS AND METHOD OF USING...

Antibodies Directed Against Programmed Death-1(PD-1)

PD-1 Binding Proteins and Methods of Use Thereof

FcRn Antibodies and Methods of Use Thereof

ANTIBODIES DIRECTED AGAINST T CELL IMMUNOGLOBULIN AND MUCIN PROTEIN...

PD-1 AGONIST AND METHOD OF USING SAME

ANTIBODIES DIRECTED AGAINST T CELL IMMUNOGLOBULIN AND MUCIN PROTEIN...

ANTIBODY AGENTS DIRECTED AGAINST LYMPHOCYTE ACTIVATION GENE-3 (LAG-...

Antibodies Directed Against Programmed Death-1 (PD-1)

FcRn Antibodies and Methods of Use Thereof

Antibodies Directed Against Programmed Death-1(PD-1)

Antibodies Directed Against Lymphocyte Activation Gene 3 (LAG-3)

FcRn Antibodies and Methods of Use Thereof

PD-1 BINDING PROTEINS AND METHODS OF USE THEREOF

ANTIBODIES DIRECTED AGAINST T CELL IMMUNOGLOBULIN AND MUCIN PROTEIN...

ANTIBODIES DIRECTED AGAINST T CELL IMMUNOGLOBULIN AND MUCIN PROTEIN...

ANTIBODIES DIRECTED AGAINST LYMPHOCYTE ACTIVATION GENE 3 (LAG-3)

ANTIBODIES DIRECTED AGAINST PROGRAMMED DEATH- 1 (PD-1)

ANTIBODIES DIRECTED AGAINST LYMPHOCYTE ACTIVATION GENE 3 (LAG-3)

ANTIBODIES DIRECTED AGAINST T CELL IMMUNOGLOBULIN AND MUCIN PROTEIN...

ANTIBODIES DIRECTED AGAINST PROGRAMMED DEATH-1 (PD-1)

FCRN ANTIBODIES AND METHODS OF USE THEREOF

PD-1 BINDING PROTEINS AND METHODS OF USE THEREOF

ANTIBODIES DIRECTED AGAINST PROGRAMMED DEATH-1 (PD-1)

Rapid Generation of Anti-Idiotypic Antibodies

Anti-mouse CD20 antibodies and uses thereof